Eli Lilly and Company (BIT:1LLY)
738.30
+80.10 (12.17%)
At close: Apr 17, 2025, 5:30 PM CET
Eli Lilly and Company Revenue
In the year 2024, Eli Lilly and Company had annual revenue of $45.04B USD with 32.00% growth. Eli Lilly and Company had revenue of $13.53B in the quarter ending December 31, 2024, with 44.68% growth.
Revenue
$45.04B
Revenue Growth
+32.00%
P/S Ratio
15.25
Revenue / Employee
$958.36K
Employees
47,000
Market Cap
663.31B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UniCredit | 23.99B |
Intesa Sanpaolo | 25.38B |
Enel SpA | 78.95B |
Ferrari | 6.68B |
Assicurazioni Generali | 55.30B |
Eni S.p.A. | 91.17B |
Leonardo S.p.a. | 17.76B |
Stellantis | 156.88B |